Sentinel lymph node biopsy remains a standard approach to treating patients with breast cancer who have no signs of obvious axillary metastases. However, fewer axillary dissections are performed today on patients with sentinel lymph node metastasis. Consequently, this has reduced the role of intraoperative frozen section analysis in decision making for axillary dissection. The aim of the present study was to evaluate the reliability of sentinel lymph node biopsy and permanent section analysis and their effects on reoperation rates in patients with early-stage breast cancer. Our study investigated 436 consecutive patients who had undergone operations for clinical T1-3 breast cancer with no lymph node involvement (T1-3, NO) and with sentinel lymph node analyses performed using a permanent section method. The subsequent treatment management of patients with postoperative pathology reports was examined. Breast-conserving surgery was performed on 418 patients, and mastectomy was performed on 18 patients. No metastases were detected in sentinel lymph nodes in 303 (69.4%) patients, and a single lymph node metastasis was detected in 98 (22.4%) patients. Metastases were detected in two lymph nodes in 30 patients and in three or more lymph nodes in 5 patients. After evaluation, a multidisciplinary tumor board made the decision to perform axillary dissection in only 2 of these 5 patients. Considering the low reoperation rates, permanent section analyses appear to be sufficiently safe for patients with breast cancer. Given the associated factors, such as costs, operational time, and workload, we believe that permanent section analysis should be introduced into routine implementation. Retrospectively registered.
Background and Objectives: The optimal timing of surgery after preoperative fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy (ChT) in gastric cancer (GC) remains unclear. We aimed to evaluate the association between time to surgery (TTS) and pathological as well as survival outcomes in patients treated with perioperative FLOT. Materials and Methods: This retrospective cohort study included 76 patients with locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who underwent curative-intent surgery after preoperative FLOT at a single tertiary center. TTS was defined as the interval between completion of preoperative FLOT and surgery. Patients were categorized into two groups according to TTS: ≤4 weeks and >4 weeks. Pathological response (PR) was assessed using the Becker tumor regression grading system. The primary endpoint was PR, including tumor regression grade and pathological complete response (pCR). Secondary endpoint was overall survival (OS). Results: The median TTS was 31 days (IQR, 21–47). Forty-five (59.2%) patients underwent surgery within 4 weeks. Favorable PR was more frequently observed in the ≤4-week group. Becker TRG 0–1 was significantly more common among patients undergoing surgery within 4 weeks compared with those undergoing surgery after more than 4 weeks (26.2% vs. 6.5%, p = 0.03). Similarly, pCR was observed exclusively in the ≤4-week group (14.3% vs. 0%, p = 0.02). ypN0 status was numerically higher in the ≤4-week group (54.7% vs. 32.2%, p = 0.05). Postoperative complication rates did not differ significantly between groups (4.8% vs. 12.9%, p = 0.17). In multivariable Cox regression analysis, TTS was not independently associated with OS, whereas poor tumor differentiation remained an independent predictor of worse survival (HR 2.57, 95% CI 1.17–5.63, p = 0.01). Conclusions: Among patients treated with preoperative FLOT, surgery within 4 weeks was associated with improved PR without an apparent increase in postoperative morbidity. However, earlier surgery was not independently associated with improved OS. These findings suggest that prolonged delay after preoperative FLOT may not be necessary in clinically recovered patients and support the need for prospective multicenter studies to define the optimal surgical interval in FLOT-treated GC.
Background/Objectives: Acute kidney injury (AKI) is a frequent complication following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). The association between preoperative inflammatory and immune-nutritional indices and postoperative AKI after CRS-HIPEC remains unclear. We aimed to investigate whether these prespecified candidate preoperative markers are associated with postoperative AKI in patients undergoing CRS-HIPEC. Methods: This retrospective single-center study included 87 patients who underwent CRS-HIPEC between October 2022 and April 2025. All received intraoperative cisplatin and mitomycin C. AKI was defined according to Kidney Disease: Improving Global Outcomes serum creatinine criteria. Preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, pan-immune-inflammation value, systemic inflammation response index, and C-reactive protein–albumin–lymphocyte (CALLY) index were calculated from routine laboratory parameters. Each candidate marker was evaluated in a separate model adjusted for age and sex, and then in a second model additionally adjusted for baseline estimated glomerular filtration rate. Discriminatory performance was assessed using receiver operating characteristic analysis. The CALLY index was calculated using albumin in g/dL, lymphocyte count in ×109/L, and C-reactive protein in mg/L. Results: AKI developed in 24 patients (27.6%). In-hospital mortality was higher in patients with AKI than in those without AKI (25.0% vs. 1.6%; p = 0.002). A higher log10-transformed CALLY index remained associated with lower odds of AKI after adjustment for age and sex (adjusted OR, 0.276; 95% CI, 0.113–0.673; p = 0.005). The CALLY index had the numerically highest AUC among the evaluated indices, with moderate discriminatory performance (AUC, 0.708; 95% CI, 0.579–0.836). A data-derived exploratory cutoff of ≤1.640 yielded 79.2% sensitivity and 63.5% specificity. Conclusions: In this selected retrospective cohort of patients without established chronic kidney disease, a lower preoperative CALLY index was associated with postoperative AKI and showed moderate discrimination as an individual marker. The data-derived threshold should be considered exploratory and requires independent validation before clinical application.